Aveanna Healthcare Holdings Inc is a medical care facilities business based in the US. Aveanna Healthcare shares (AVAH) are listed on the NASDAQ and all prices are listed in US Dollars. Aveanna Healthcare employs 33,000 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $2.37 |
|---|---|
| 52-week range | $2.09 - $12.55 |
| 50-day moving average | $2.83 |
| 200-day moving average | $5.40 |
| Wall St. target price | $6.05 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.54 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.37 from 2022-07-01
| 1 week (2022-06-24) | -9.89% |
|---|---|
| 1 month (2022-06-02) | -23.30% |
| 3 months (2022-04-01) | -30.70% |
| 6 months (2021-12-31) | -67.97% |
| 1 year (2021-07-02) | -80.99% |
|---|---|
| 2 years (2020-06-28) | N/A |
| 3 years (2019-06-28) | N/A |
| 5 years (2017-06-28) | N/A |
Valuing Aveanna Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aveanna Healthcare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Aveanna Healthcare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $116.1 million.
The EBITDA is a measure of a Aveanna Healthcare's overall financial performance and is widely used to measure a its profitability.
To put Aveanna Healthcare's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $1.7 billion |
|---|---|
| Operating margin TTM | 5.59% |
| Gross profit TTM | $542.4 million |
| Return on assets TTM | 2.87% |
| Return on equity TTM | -20.71% |
| Profit margin | -5.7% |
| Book value | $3.62 |
| Market capitalisation | $417.5 million |
TTM: trailing 12 months
We're not expecting Aveanna Healthcare to pay a dividend over the next 12 months.
You may also wish to consider:
Aveanna Healthcare Holdings Inc. , a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.